|Bid||83.13 x 500|
|Ask||83.15 x 500|
|Day's Range||82.91 - 83.29|
|52 Week Range||66.93 - 86.90|
|PE Ratio (TTM)||31.25|
|Dividend & Yield||2.72 (3.28%)|
|1y Target Est||N/A|
Late last week, Biogen (BIIB) and six other pharma and biotech stocks were in the news due to the pricing of their multiple sclerosis ("MS") drugs.
These are the stocks posting the largest moves before the bell.
The first new malaria drug to emerge for 20 years is beginning clinical trials in nine countries across Africa and Asia. KAF156 could be "a game changer", its developers say, at a time when the ...